Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dodds

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Translational Science|October 11, 2019
Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500Laura Bonifacio, Michael Dodds, David Prohaska, et al.
BMC Oral Health|September 13, 2019
Resistance and resilience to experimental gingivitis: a systematic scoping reviewCharifa Zemouri, Nicholas S Jakubovics, Wim Crielaard, et al.
The Journal of Clinical Dentistry|June 10, 2015
Crossover clinical investigation of a whitening chewing gum for inhibiting dental stain formation in conjunction with tooth brushingJeffery L Milleman, Kimberly R Milleman, Carl J Kleber, et al.
British Journal of Clinical Pharmacology|December 29, 2020
Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2Kashyap Patel, Michael Dodds, Antonio Gonçalves, et al.
Chemical Communications (Cambridge, England)|June 2, 2015
Molecular basis of Streptococcus mutans sortase A inhibition by the flavonoid natural product trans-chalconeDaynea J Wallock-Richards, Jon Marles-Wright, David J Clarke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2007
Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activitySylvie M Guichard, Janet S Macpherson, Iain Mayer, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
The American Journal of Chinese Medicine|September 16, 2016
Magnolia officinalis L. Fortified Gum Improves Resistance of Oral Epithelial Cells Against InflammationJessica Walker, Julia Maria Imboeck, Joel Michael Walker, et al.
Cancer Research|August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivoKevin Morgan, Alan J Stewart, Nicola Miller, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Translational Science|October 11, 2019
Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500Laura Bonifacio, Michael Dodds, David Prohaska, et al.
BMC Oral Health|September 13, 2019
Resistance and resilience to experimental gingivitis: a systematic scoping reviewCharifa Zemouri, Nicholas S Jakubovics, Wim Crielaard, et al.
The Journal of Clinical Dentistry|June 10, 2015
Crossover clinical investigation of a whitening chewing gum for inhibiting dental stain formation in conjunction with tooth brushingJeffery L Milleman, Kimberly R Milleman, Carl J Kleber, et al.
British Journal of Clinical Pharmacology|December 29, 2020
Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2Kashyap Patel, Michael Dodds, Antonio Gonçalves, et al.
Chemical Communications (Cambridge, England)|June 2, 2015
Molecular basis of Streptococcus mutans sortase A inhibition by the flavonoid natural product trans-chalconeDaynea J Wallock-Richards, Jon Marles-Wright, David J Clarke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2007
Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activitySylvie M Guichard, Janet S Macpherson, Iain Mayer, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
The American Journal of Chinese Medicine|September 16, 2016
Magnolia officinalis L. Fortified Gum Improves Resistance of Oral Epithelial Cells Against InflammationJessica Walker, Julia Maria Imboeck, Joel Michael Walker, et al.
Cancer Research|August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivoKevin Morgan, Alan J Stewart, Nicola Miller, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Pageof 3